FDA.reportPublic FDA data

bexarotene 75 MG Oral Capsule

RxCUI
308725
RxNorm name
bexarotene 75 MG Oral Capsule
Display name
bexarotene 75 MG Oral Capsule
Full name
bexarotene 75 MG Oral Capsule
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BexaroteneBEXAROTENEAvKAREf9514265-6e2c-9030-e053-6394a90aa04b2025-10-13Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 308725
BexaroteneBEXAROTENEANI Pharmaceuticals, Inc.e713c60d-f623-4260-b0ca-db07e1365fd22025-09-12Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 308725
BexaroteneBEXAROTENECamber Pharmaceuticals, Inc.374c42b1-3d7f-4ca3-9d3a-2a111286f7ca2025-01-20Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 308725
bexaroteneBEXAROTENEActavis Pharma, Inc.3292c63c-052f-4f28-b739-530a86e660bf2024-02-29Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 308725
BexaroteneBEXAROTENEUpsher-Smith Laboratories, Inc.7437a43f-172a-4f4e-8132-fe23b00224f92023-03-31Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 308725
BexaroteneBEXAROTENEAmneal Pharmaceuticals NY LLCd7fc7c7b-2ecf-4543-8bb4-9b4415d666132022-12-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 308725
TargretinBEXAROTENEBausch Health US, LLC1d056725-0576-4338-8089-6336e768ccdc2020-04-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 308725
BexaroteneBEXAROTENEMylan Pharmaceuticals Inc.2d1eb4bd-51f9-4c9b-9fb1-0be5e30a3dc52018-06-13Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 308725

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 8 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
1d056725-0576-4338-8089-6336e768ccdcbexarotene 75 MG Oral Capsule [PSN] · bexarotene 75 MG Oral Capsule [SCD]215These highlights do not include all the information needed to use TARGRETIN safely and effectively. See full prescribing information for TARGRETIN. TARGRETIN ® (bexarotene) capsules, for oral use Initial U.S. Approval: 199920200430
d7fc7c7b-2ecf-4543-8bb4-9b4415d66613bexarotene 75 MG Oral Capsule [PSN] · bexarotene 75 MG Oral Capsule [SCD]212These highlights do not include all the information needed to use BEXAROTENE CAPSULES safely and effectively. See full prescribing information for BEXAROTENE CAPSULES. BEXAROTENE capsules, for oral use Initial U.S. Approval: 199920221230
e713c60d-f623-4260-b0ca-db07e1365fd2bexarotene 75 MG Oral Capsule [PSN] · bexarotene 75 MG Oral Capsule [SCD]28These highlights do not include all the information needed to use BEXAROTENE CAPSULES safely and effectively. See full prescribing information for BEXAROTENE CAPSULES. BEXAROTENE capsules, for oral use Initial U.S. Approval: 199920250912
3292c63c-052f-4f28-b739-530a86e660bfbexarotene 75 MG Oral Capsule [PSN] · bexarotene 75 MG Oral Capsule [SCD]28These highlights do not include all the information needed to use BEXAROTENE CAPSULES safely and effectively. See full prescribing information for BEXAROTENE CAPSULES. BEXAROTENE capsules, for oral use Initial U.S. Approval: 199920240229
2d1eb4bd-51f9-4c9b-9fb1-0be5e30a3dc5bexarotene 75 MG Oral Capsule [PSN] · bexarotene 75 MG Oral Capsule [SCD]25These highlights do not include all the information needed to use BEXAROTENE CAPSULES safely and effectively. See full prescribing information for BEXAROTENE CAPSULES . BEXAROTENE capsules, for oral use Initial U.S. Approval: 199920180613
7437a43f-172a-4f4e-8132-fe23b00224f9bexarotene 75 MG Oral Capsule [PSN] · bexarotene 75 MG Oral Capsule [SCD]23These highlights do not include all the information needed to use BEXAROTENE CAPSULES safely and effectively. See full prescribing information for BEXAROTENE CAPSULES. BEXAROTENE capsules, for oral use Initial U.S. Approval: 199920230331
f9514265-6e2c-9030-e053-6394a90aa04bbexarotene 75 MG Oral Capsule [PSN] · bexarotene 75 MG Oral Capsule [SCD]22Bexarotene Capsules Rx Only These highlights do not include all the information needed to use BEXAROTENE CAPSULES safely and effectively. See full prescribing information for BEXAROTENE CAPSULES. Initial U.S. Approval: 199920251013
374c42b1-3d7f-4ca3-9d3a-2a111286f7cabexarotene 75 MG Oral Capsule [PSN] · bexarotene 75 MG Oral Capsule [SCD]21HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BEXAROTENE CAPSULES safely and effectively. See full prescribing information for BEXAROTENE CAPSULES. BEXAROTENE capsules, for oral use Initial U.S. Approval: 199920250120